Michael Cheung
About Michael Cheung
Michael Cheung is the Senior Director of US REMS Strategy & Submissions Lead at Bristol Myers Squibb, with extensive experience in clinical drug development and safety management.
Professional Background
Michael Cheung holds the position of Senior Director, US REMS Strategy & Submissions Lead at Bristol Myers Squibb. He has accumulated extensive experience in the pharmaceutical industry, having held various roles over the past two decades. His experience spans across notable companies such as MyoKardia, VIVUS, Inc., Allergan, Synteract, Inc., Valeant Pharmaceuticals, and Profil, where he specialized in regulatory strategies, risk management, medical affairs operations, and clinical drug safety.
Educational Background
Michael Cheung achieved a Doctor of Health Science with a concentration in Global Health from A.T. Still University of Health Sciences. He also holds a Master of Science in Regulatory Affairs with a concentration in Drugs, Biologics & Medical Devices from Northeastern University. Additionally, he earned a Bachelor of Science in Kinesiology with a concentration in Fitness, Nutrition & Health from San Diego State University. This diverse educational background has equipped him with the expertise required for his roles in the pharmaceutical industry.
Roles in Clinical Drug Development
Throughout his career, Michael Cheung has worked in Phase I-IV clinical drug development and safety and risk management. His expertise in this area includes significant roles at VIVUS, Inc. as Director of Risk Management and Medical Affairs Operations, and at Allergan as Medical Affairs Specialist - Phase IV Clinical Research. His work has been instrumental in ensuring the safety and efficacy of pharmaceutical products through meticulous safety surveillance and risk management protocols.
Specialization in REMS Programs
Known for his expertise in Risk Evaluation & Mitigation Strategy (REMS) programs, Michael Cheung has expanded these programs significantly during his tenure in various organizations. At Bristol Myers Squibb, he leads the US REMS Strategy & Submissions, ensuring that risk management strategies are adequately developed and implemented to meet regulatory requirements and enhance patient safety.
Experience in Global Medical Affairs
Michael Cheung's background in Global Medical Affairs Programs is marked by his role at Allergan. Here, he contributed to Phase IV clinical research and managed programs that integrated global health considerations. His ability to navigate and influence within large, diverse, and matrixed organizations has been pivotal in his success in this domain, further strengthening his contributions to the pharmaceutical sector.